Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7,227,333
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
23,177,080
-
Shares change
-
-22,045
-
Total reported value, excl. options
-
$112,175,583
-
Value change
-
-$609,942
-
Put/Call ratio
-
2.04%
-
Number of buys
-
36
-
Number of sells
-
-43
-
Price
-
$4.84
Significant Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q3 2020
95 filings reported holding KZR - Kezar Life Sciences Inc - COMMON-STOCK as of Q3 2020.
Kezar Life Sciences Inc - COMMON-STOCK (KZR) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23,177,080 shares
.
Largest 10 shareholders include Bellevue Group AG (4,533,148 shares), FRANKLIN RESOURCES INC (2,026,900 shares), BlackRock Inc. (1,994,302 shares), FMR LLC (1,865,733 shares), VANGUARD GROUP INC (1,564,493 shares), Cormorant Asset Management, LP (931,800 shares), Opaleye Management Inc. (678,000 shares), MILLENNIUM MANAGEMENT LLC (651,129 shares), Candriam Luxembourg S.C.A. (600,000 shares), and Alyeska Investment Group, L.P. (588,502 shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.